VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
XTLB
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
XTLBXTL Biopharmaceuticals Ltd.
$2.70$297068
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksXTLBPrice History

XTLB logoXTL Biopharmaceuticals Ltd. (XTLB) Stock Price History

Historical prices from 2005 to 2026

$2.70+0.21  (+8.43%)close Jul 2
Returns
1M
+17.9%
3M
+11.1%
YTD
+12.5%
1Y
-43.8%
3Y
-12.3%
5Y
-29.7%
ATH$2,400.00Sep 2005-99.9%
ATL$1.05Jan 2026pre-split
Avg Vol (50D)2.5M/ day
52-Week Range$1.05 — $10.28
LowCurrent: $2.70High

Loading 10-year price history...

XTLB Historical Performance

1 YearTotal Return
-43.8%
Price: -43.8%
3 YearsTotal Return
-32.5%
CAGR: -12.3%
Price: -32.5%
5 YearsTotal Return
-82.9%
CAGR: -29.7%
Price: -82.9%
YTD
+12.5%

XTLB Annual Returns

Year-by-year price performance · 2005–2026

Best+327.3%2010
Worst-98.3%2008
Up years7/22
2005-32.2%
2006-65.4%
2007+5.2%
2008-98.3%
2009+66.7%
2010+327.3%
2011-24.0%
2012+81.0%
2013-60.9%
2014-36.5%
2015-27.3%
2016-57.7%
2017-29.5%
2018-29.1%
2019-22.2%
2020+133.1%
2021-20.9%
2022-58.0%
2023-16.5%
2024+107.7%
2025-70.6%
2026+27.1%
2005 annual price return
-32.2%
2006 annual price return
-65.4%
2007 annual price return
+5.2%
2008 annual price return
-98.3%
2009 annual price return
+66.7%
2010 annual price return
+327.3%
2011 annual price return
-24.0%
2012 annual price return
+81.0%
2013 annual price return
-60.9%
2014 annual price return
-36.5%
2015 annual price return
-27.3%
2016 annual price return
-57.7%
2017 annual price return
-29.5%
2018 annual price return
-29.1%
2019 annual price return
-22.2%
2020 annual price return
+133.1%
2021 annual price return
-20.9%
2022 annual price return
-58.0%
2023 annual price return
-16.5%
2024 annual price return
+107.7%
2025 annual price return
-70.6%
2026 annual price return
+27.1%
LessMore
Alpha vs S&P 500
1Y-67.6%
3Y-35.9%
5Y-38.7%

Price returns only.

Download Historical Data

5,240 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

XTLB Stock Price Trajectory (2005–2026)

As of July 6, 2026, XTL Biopharmaceuticals Ltd. (XTLB) trades at $2.70, representing a -43.8% return over the past year. The stock has delivered a -82.9% total return over five years (-29.7% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $2,400.00 on September 1, 2005. From this peak, XTLB has corrected -99.9%, currently trading 19% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers NRXP (+16.6% 1Y), SIGA (-42.2% 1Y), and BFRI (+46.4% 1Y), XTLB has underperformed the peer group average. Compare XTLB vs NRXP →

XTLB Historical Price Data · from 2005

Rows 1–50 of 5,240
Date Open High Low Close Volume Change %
2026-07-022.442.762.362.7044K+8.43%
2026-07-012.412.632.152.49288K-8.79%
2026-06-302.542.802.362.7395K+15.68%
2026-06-292.372.372.312.363K0.00%
2026-06-262.452.652.232.3635K-7.99%
2026-06-252.472.572.412.5623K-8.01%
2026-06-242.542.802.522.796K-0.06%
2026-06-232.602.872.602.7921K+3.33%
2026-06-222.542.822.362.7026K+6.30%
2026-06-182.412.542.312.5411K+4.96%
2026-06-172.462.472.402.429K+1.68%
2026-06-162.402.462.322.388K+3.48%
2026-06-152.312.332.122.3014K+7.98%
2026-06-122.222.392.122.139K-8.97%
2026-06-112.382.432.282.345K+0.86%
2026-06-102.282.322.232.322K0.00%
2026-06-092.282.382.242.3223K+4.04%
2026-06-082.272.292.062.2326K+8.25%
2026-06-052.232.312.022.0626K-7.62%
2026-06-042.262.322.222.237K-1.33%
2026-06-032.312.352.202.2610K-1.31%
2026-06-022.422.422.262.298K-4.58%
2026-06-012.482.512.392.4017K-1.64%
2026-05-292.492.492.392.449K-0.81%
2026-05-282.542.542.332.469K+0.82%
2026-05-272.522.592.382.4410K+2.52%
2026-05-262.472.552.252.3844K-5.18%
2026-05-222.502.642.462.5125K+0.80%
2026-05-212.562.562.472.497K-3.11%
2026-05-202.512.582.462.5728K+1.58%
2026-05-192.532.532.452.5355K-6.40%
2026-05-182.592.702.562.7054K+3.56%
2026-05-152.582.612.522.6127K-3.33%
2026-05-142.692.732.632.7015K-1.10%
2026-05-132.632.752.512.7320K+1.49%
2026-05-122.892.922.642.69108K-5.61%
2026-05-112.692.852.582.8560K+12.20%
2026-05-082.742.742.452.5443K-4.87%
2026-05-073.063.182.602.67102K-17.85%
2026-05-063.633.643.003.25128K-11.20%
2026-05-053.534.013.513.66163K-4.19%
2026-05-043.524.003.463.82340K+4.66%
2026-05-013.934.003.493.651.74M-6.41%
2026-04-303.563.953.113.901.56M+9.55%
2026-04-293.804.873.223.56113.44M+54.78%
2026-04-282.322.322.282.3011K-3.77%
2026-04-272.432.642.392.399K-1.65%
2026-04-242.392.452.392.434K-0.41%
2026-04-232.492.552.422.448K-2.79%
2026-04-222.592.622.512.513K+1.62%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

XTLB — Frequently Asked Questions

Quick answers to the most common questions about buying XTLB stock.

How has XTLB stock performed recently?

XTLB declined -43.8% over the past year, below its 5-year annualized CAGR of -29.7%. The stock trades below its 200-day moving average, reflecting the downtrend.

What is XTLB's all-time high price?

XTL Biopharmaceuticals Ltd. reached $2400.00 on 2005-09-01. The 52-week high is $10.28. Current 1-year return of -43.8% places the stock further from historical peaks.

Where can I download XTLB historical price data?

This page provides XTLB daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2005-2026, downloadable in CSV format.

478 data points · sampled from 5,240